Clinical trial
Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
NCT02423954
Study timeline
Study start (actual)2015-04-01Date precision: month
Registry last updated2018-07-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Cancerunresolved
Pancreatic Cancerunresolved
Renal Cell Cancerunresolved
Non Small Cell Lung Cancerunresolved
Colorectal Carcinomaunresolved
Endometrialunresolved
Uterineunresolved
Interventions
TemsirolimusDRUG · verified · RxNorm: temsirolimus
IrinotecanDRUG · verified · RxNorm: irinotecan
nivolumabDRUG · verified · RxNorm: nivolumab
Sponsors & collaborators
Western Regional Medical Centerlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02423954 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.